التفاصيل البيبلوغرافية
| العنوان: |
Clinical and microarray analysis of breast cancers of all subtypes from two prospective preoperative chemotherapy studies. |
| المؤلفون: |
Okuma, H S, Koizumi, F, Hirakawa, A, Nakatochi, M, Komori, O, Hashimoto, J, Kodaira, M, Yunokawa, M, Yamamoto, H, Yonemori, K, Shimizu, C, Fujiwara, Y, Tamura, K |
| المصدر: |
British Journal of Cancer; 8/9/2016, Vol. 115 Issue 4, p411-419, 9p, 5 Charts, 2 Graphs |
| مصطلحات موضوعية: |
ANTINEOPLASTIC agents, CANCER chemotherapy, PROTEIN metabolism, RNA metabolism, BREAST tumors, CANCER, CELL receptors, COMBINED modality therapy, COMPARATIVE studies, FLUOROURACIL, HYDROCARBONS, LONGITUDINAL method, RESEARCH methodology, MEDICAL cooperation, PACLITAXEL, PROGNOSIS, RESEARCH, TUMOR classification, EVALUATION research, TREATMENT effectiveness, CYCLOPHOSPHAMIDE, TISSUE arrays, EPIRUBICIN, GENE expression profiling |
| مستخلص: |
Background: We aimed to analyse clinical and gene expression profiles to predict pathologic complete response and disease-free survival using two consecutive, prospective, preoperative chemotherapy trial cohorts.Methods: Clinicopathological and gene expression data were evaluated in a cohort from two consecutive phase II preoperative studies that included patients with stage IIA-IIIC breast cancer of all subtypes. Analysed specimens were obtained before preoperative chemotherapy, and cDNA microarray analyses were performed using the Affymetrix Gene Chip U133 plus 2.0.Results: Between December 2005 and December 2010, 122 patients were analysed. The pathologic complete response rate was significantly higher in HER2+ and HR-/HER2- cancers. Age, pathologic complete response, HR-/HER2- status, and lymph node positivity (⩾4) were significant poor prognostic factors for disease-free survival. For the cDNA microarray analyses, sufficient tumour samples were available from 78 of the 107 patients (73%). An 8-gene signature predictive of pathologic complete response and a 17-gene signature predictive of prognosis were identified. Patients were categorised into low-risk (n=45) and high-risk groups (n=33) (HR 70.0, P=0.004).Conclusions: This study yielded preliminary data on the expression of specific genes predicting pathologic complete response and disease-free survival in a cohort of chemonaïve breast cancer patients. Further validation may distinguish those who would benefit most from perioperative chemotherapy as well as those needing further intervention. [ABSTRACT FROM AUTHOR] |
|
Copyright of British Journal of Cancer is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder